In a subsequent study in 2015, the same group showed that application of even higher radiation doses did not lead to toxic side effects after instillation of 213Bi-Anti-EGFR-mAb in bladder cancer-bearing xenografts. This evidence concerns the gene EGFR and urinary bladder cancer.